Cefadroxil

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 886 publications

ESBL and Integron Profiles in Pediatric EPEC/STEC.

ESBL and Integron Profiles in Pediatric EPEC/STEC.

Journal: The Pediatric infectious disease journal

Published: January 22, 2026

Gepotidacin (Blujepa) - a new antibiotic for uncomplicated UTI.

Gepotidacin (Blujepa) - a new antibiotic for uncomplicated UTI.

Journal: The Medical letter on drugs and therapeutics

Published: January 08, 2026

Antibiotics in Tactical Combat Casualty Care 2025: TCCC Change 25-1.

Antibiotics in Tactical Combat Casualty Care 2025: TCCC Change 25-1.

Journal: Journal of special operations medicine : a peer reviewed journal for SOF medical professionals

Published: December 01, 2025

Cefadroxil-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome After Double Mastectomy for Ductal Carcinoma In Situ: A Case Report.

Cefadroxil-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome After Double Mastectomy for Ductal Carcinoma In Situ: A Case Report.

Journal: Cureus

Published: November 30, 2025

Postoperative Oral Antibiotics Continue to Increase in Prevalence Without Associated Improvements in One-Year Periprosthetic Joint Infection Rates.

Postoperative Oral Antibiotics Continue to Increase in Prevalence Without Associated Improvements in One-Year Periprosthetic Joint Infection Rates.

Journal: The Journal of arthroplasty

Published: November 30, 2025

Structure-dependent transformation of cephalosporin antibiotics at MnO2 surface mediated by iodide and formation of highly toxic iodinated products.

Structure-dependent transformation of cephalosporin antibiotics at MnO2 surface mediated by iodide and formation of highly toxic iodinated products.

Journal: Water research

Published: November 25, 2025

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil.

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil.

Journal: Open forum infectious diseases

Published: November 07, 2025

Sulopenem etzadroxil/probenecid (Orlynvah) for uncomplicated UTIs.

Sulopenem etzadroxil/probenecid (Orlynvah) for uncomplicated UTIs.

Journal: The Medical letter on drugs and therapeutics

Published: November 05, 2025

Primary Genital HSV-2 Infection in a Resource-Limited Setting: Diagnostic Challenges and Clinical Implications.

Primary Genital HSV-2 Infection in a Resource-Limited Setting: Diagnostic Challenges and Clinical Implications.

Journal: Cureus

Published: October 31, 2025

Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman with Breast Cancer: A Case Report.

Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman with Breast Cancer: A Case Report.

Journal: The American journal of case reports

Published: October 24, 2025

Amoxicillin-induced Erythema Scarlatiniforme Desquamativum Recidivans with cross-reactivity to cefadroxil in a child: A case report and review of literature.

Amoxicillin-induced Erythema Scarlatiniforme Desquamativum Recidivans with cross-reactivity to cefadroxil in a child: A case report and review of literature.

Journal: British journal of clinical pharmacology

Published: October 23, 2025

Resistance of uropathogens to gepotidacin: A systematic review of in vitro antimicrobial susceptibility studies.

Resistance of uropathogens to gepotidacin: A systematic review of in vitro antimicrobial susceptibility studies.

Journal: International journal of antimicrobial agents

Published: October 22, 2025

Showing 1-12 of 886

Last Updated: 04/28/2026